---
title: "Adagio Medical Holdings (ADGM) news: convertible notes"
url: "https://aibio.space/companies/adagio-medical/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "ADGM convertible notes, Nasdaq notice and merger news: Adagio Medical converts $776,111 of notes into 4,978,869 shares. Adagio Medical Holdings, Inc."
---

ADGM Adagio Medical Holdings, Inc. NASDAQ · United States

# Adagio Medical Holdings (ADGM) news ADGM convertible notes, Nasdaq notice and merger news

Financings · 2026-10-01

## [Adagio Medical converts $776,111 of notes into 4,978,869 shares](https://aibio.space/news/adagio-medical-converts-776-111-notes-4-978-869-shares/)

A holder converted senior secured convertible notes at alternate prices set during the company's strategic review, according to an October 1 filing.

## Latest Adagio Medical Holdings news

1. 2026-09-23 Distress [Adagio Medical starts strategic review and cuts workforce](https://aibio.space/news/adagio-medical-starts-strategic-review-cuts-workforce/) The board opened a formal process to explore alternatives that may include an acquisition, merger or other transaction, and the company has set no timetable.
2. 2026-08-14 Listings [Adagio Medical receives Nasdaq notice on stockholders' equity](https://aibio.space/news/adagio-medical-receives-nasdaq-notice-stockholders-equity/) The company reported stockholders' equity of negative $415,000 at June 30, 2026, below Nasdaq's $2,500,000 minimum, and must submit a compliance plan by September 28, 2026.
3. 2026-06-12 Listings [Adagio Medical gets Nasdaq bid price notice, has until December 9](https://aibio.space/news/adagio-medical-gets-nasdaq-bid-price-notice-has-until-december-9/) The company's common stock traded below $1.00 for 30 consecutive business days, and it has 180 calendar days to regain compliance.

## Adagio Medical Holdings at a glance

- **Ticker**: ADGM

- **Listing**: NASDAQ

- **Country**: United States

- **Cash, Jun 30, 2026**: $7.7 million

### Related companies

- [Intercure](https://aibio.space/companies/intercure/) NASDAQ: INCR
- [NIKA PHARMACEUTICALS, INC](https://aibio.space/companies/nika-pharmaceuticals/) OTC: NIKA
- [iSpecimen](https://aibio.space/companies/ispecimen/) NASDAQ: ISPC
- [Hongchang International Co.](https://aibio.space/companies/hongchang-international/) OTC: HCIL
- [Lifeloc Technologies](https://aibio.space/companies/lifeloc-technologies/) OTC: LCTC
- [GUIDED THERAPEUTICS INC](https://aibio.space/companies/guided-therapeutics/) OTC: GTHP
- [Enovis CORP](https://aibio.space/companies/enovis/) NYSE: ENOV
- [VYCOR MEDICAL INC](https://aibio.space/companies/vycor-medical/) OTC: VYCO

### Also on NASDAQ

- [PRECISION OPTICS CORPORATION, INC.](https://aibio.space/companies/precision-optics/) POCI
- [ProMIS Neurosciences](https://aibio.space/companies/promis-neurosciences/) PMN
- [Syndax Pharmaceuticals](https://aibio.space/companies/syndax-pharmaceuticals/) SNDX
- [RadNet](https://aibio.space/companies/radnet/) RDNT
- [AnaptysBio](https://aibio.space/companies/anaptysbio/) ANAB
- [Lucid Diagnostics](https://aibio.space/companies/lucid-diagnostics/) LUCD

## Adagio Medical Holdings annual financials

| Line | FY2025 | FY2023 |
|---|---|---|
| Revenue | [$0](https://www.sec.gov/Archives/edgar/data/2006986/000200698626000003/) | [$300,000](https://www.sec.gov/Archives/edgar/data/2006986/000155837025003849/) |
| Research and development | [$10.6 million](https://www.sec.gov/Archives/edgar/data/2006986/000200698626000003/) | [$15.4 million](https://www.sec.gov/Archives/edgar/data/2006986/000155837025003849/) |
| Net income (loss) | [-$25.1 million](https://www.sec.gov/Archives/edgar/data/2006986/000200698626000003/) | [-$36.6 million](https://www.sec.gov/Archives/edgar/data/2006986/000155837025003849/) |
| Cash from operations | [-$19.0 million](https://www.sec.gov/Archives/edgar/data/2006986/000200698626000003/) | [-$25.7 million](https://www.sec.gov/Archives/edgar/data/2006986/000155837025003849/) |
| Cash and equivalents | [$17.1 million](https://www.sec.gov/Archives/edgar/data/2006986/000110465926093790/) | [$1.4 million](https://www.sec.gov/Archives/edgar/data/2006986/000155837025003849/) |

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $7.7 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

## Questions about Adagio Medical Holdings

Has Adagio Medical Holdings sold convertible notes?

Our latest story on this, dated Oct 1, 2026: "Adagio Medical converts $776,111 of notes into 4,978,869 shares". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/adagio-medical-converts-776-111-notes-4-978-869-shares/).

Has Adagio Medical Holdings received a Nasdaq deficiency notice?

Our latest story on this, dated Aug 14, 2026: "Adagio Medical receives Nasdaq notice on stockholders' equity". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/adagio-medical-receives-nasdaq-notice-stockholders-equity/).

Is Adagio Medical Holdings involved in a merger or acquisition?

Our latest story on this, dated Sep 23, 2026: "Adagio Medical starts strategic review and cuts workforce". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/adagio-medical-starts-strategic-review-cuts-workforce/).

What is the ticker symbol of Adagio Medical Holdings?

Adagio Medical Holdings, Inc. trades under the ticker ADGM on NASDAQ.

Where is Adagio Medical Holdings listed?

Adagio Medical Holdings, Inc. is listed on NASDAQ.

Which country or territory is Adagio Medical Holdings listed under?

Our directory records Adagio Medical Holdings, Inc. under United States.

Does aibio.space cover Adagio Medical Holdings?

aibio.space lists Adagio Medical Holdings, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

What was Adagio Medical Holdings's revenue last year?

$0 for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is Adagio Medical Holdings profitable?

Adagio Medical Holdings, Inc. reported a net loss of $25.1 million for the fiscal year ended Dec 31, 2025, and used $19.0 million of cash in operations, per its annual report to the SEC.

How much does Adagio Medical Holdings spend on research and development?

$10.6 million in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does Adagio Medical Holdings have?

$7.7 million in cash at Jun 30, 2026, per its 10-Q.

What is the latest Adagio Medical Holdings (ADGM) stock news?

Our latest story on Adagio Medical Holdings, dated Oct 1, 2026: "Adagio Medical converts $776,111 of notes into 4,978,869 shares". A holder converted senior secured convertible notes at alternate prices set during the company's strategic review, according to an October 1 filing. [Source](https://aibio.space/news/adagio-medical-converts-776-111-notes-4-978-869-shares/).

What is Adagio Medical Holdings's latest stock offering or financing news?

Our latest financing story, dated Oct 1, 2026: "Adagio Medical converts $776,111 of notes into 4,978,869 shares". A holder converted senior secured convertible notes at alternate prices set during the company's strategic review, according to an October 1 filing. [Source](https://aibio.space/news/adagio-medical-converts-776-111-notes-4-978-869-shares/).

How long will Adagio Medical Holdings's cash last?

From our story of Sep 23, 2026: The release does not give a cash runway or any updated operating loss for the period. [Source](https://aibio.space/news/adagio-medical-starts-strategic-review-cuts-workforce/).

Is Adagio Medical Holdings in financial distress?

Our latest distress story, dated Sep 23, 2026: "Adagio Medical starts strategic review and cuts workforce". The board opened a formal process to explore alternatives that may include an acquisition, merger or other transaction, and the company has set no timetable. [Source](https://aibio.space/news/adagio-medical-starts-strategic-review-cuts-workforce/).

## Investor discussion: Adagio Medical Holdings

Members talk about Adagio Medical Holdings (ADGM). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Adagio Medical Holdings, newest first. Each line links the filing it comes from.

1. 2026-10-26 Listings Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.07). [Source](https://www.sec.gov/Archives/edgar/data/2006986/000110465926118615/tm2628260d1_8k.htm)
2. 2026-10-13 Listings Asked shareholders to approve a reverse stock split. SEC Form DEF 14A. [Source](https://www.sec.gov/Archives/edgar/data/2006986/000114036126039339/ny20082992x2_def14a.htm)
3. 2026-10-01 Listings Asked shareholders to approve a reverse stock split. SEC Form PRE 14A. [Source](https://www.sec.gov/Archives/edgar/data/2006986/000114036126038286/ny20082992x1_pre14a.htm)
4. 2026-09-23 Distress Reported a restructuring, a workforce reduction or a review of strategic alternatives. SEC Form 8-K (Items 2.05,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/2006986/000110465926109821/adgm-20260923xex99.htm)
5. 2026-08-14 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). [Source](https://www.sec.gov/Archives/edgar/data/2006986/000110465926097242/tm2623192d2_8k.htm)
6. 2026-06-12 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). [Source](https://www.sec.gov/Archives/edgar/data/2006986/000110465926073517/tm2617882d1_8k.htm)

## Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:ADGM on TradingView](https://www.tradingview.com/symbols/NASDAQ-ADGM/).

## Listing details

Adagio Medical Holdings, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker ADGM, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: Adagio Medical Holdings, Inc.

- **Ticker**: ADGM

- **Listing**: NASDAQ

- **Country or territory**: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/adagio-medical/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Adagio Medical Holdings (ADGM) news: convertible notes", 2026-10-31, https://aibio.space/companies/adagio-medical/